The Priority Review

Clinical trials Brief

Medtronic reports positive real-world registry results for Sphere-9 and PulseSelect at APHRS 2026

Medtronic said the APEX registry included 1,050 patients with atrial fibrillation treated with the Sphere-9 catheter, reporting a 1.1% major complication rate. The REAL PULSE registry included 1,160 patients and reported a 100% acute success rate with a 0.09% acute major complication rate.

Primary source

Company press release (PR Newswire), October 22, 2026

Medtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026

Read the source: Medtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026 prnewswire.com

Machine-summarized from the source above; not independently reported. How we use automation